Detalles de la búsqueda
1.
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey.
Blood
; 140(26): 2773-2787, 2022 12 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36126318
2.
Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry.
Hematol Oncol
; 42(1): e3240, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38050405
3.
Clinical outcomes in patients with Philadelphia chromosome-positive leukemia treated with ponatinib in routine clinical practice-data from a Belgian registry.
Ann Hematol
; 100(7): 1723-1732, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33942128
4.
Diagnosis and management of PNH: Review and recommendations from a Belgian expert panel.
Eur J Haematol
; 101(6): 737-749, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30171728
5.
Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report.
Am J Hematol
; 97(8): E312-E317, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35702878
6.
The myelodysplastic syndromes: the era of understanding.
Eur J Haematol
; 94(5): 379-90, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25186093
7.
Sabatolimab plus hypomethylating agents in previously untreated patients with higher-risk myelodysplastic syndromes (STIMULUS-MDS1): a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet Haematol
; 11(1): e38-e50, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38065203
8.
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey.
Leuk Lymphoma
; 65(2): 199-208, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37966980
9.
Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022.
EClinicalMedicine
; 71: 102553, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38533127
10.
Combined Results of Two Cross-Sectional Surveys on the Participation in Clinical Trials and the e-Consent Procedure in the Landscape of Haematology.
Clin Pract
; 13(6): 1520-1531, 2023 Nov 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38131682
11.
Disease Perception Is Correlated with Health-Related Quality of Life in Patients Suffering from Myelodysplastic Syndromes: Results of the Belgian Be-QUALMS Study.
Cancers (Basel)
; 15(13)2023 Jun 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37444406
12.
Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry.
Int J Antimicrob Agents
; 62(4): 106952, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37582478
13.
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry.
EClinicalMedicine
; 58: 101939, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37041967
14.
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry.
Ther Adv Hematol
; 14: 20406207231154706, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36923264
15.
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings.
Int J Infect Dis
; 137: 98-110, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37863310
16.
Brentuximab vedotin induced uveitis.
Am J Ophthalmol Case Rep
; 26: 101440, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35243175
17.
Effectiveness and Safety of Ibrutinib for Chronic Lymphocytic Leukemia in Routine Clinical Practice: 3-Year Follow-up of the Belgian Ibrutinib Real-World Data (BiRD) Study.
Clin Hematol Int
; 4(4): 133-143, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36227519
18.
B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA).
Front Oncol
; 12: 992137, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36276116
19.
Real-world data confirming the efficacy and safety of decitabine in acute myeloid leukaemia - results from a retrospective Belgian registry study.
Acta Clin Belg
; 76(2): 98-105, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31551014
20.
Myeloablative conditioning predisposes patients for Toxoplasma gondii reactivation after allogeneic stem cell transplantation.
Clin Infect Dis
; 50(8): 1127-34, 2010 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20218875